NVO logo

Novo Nordisk A/S (NVO) Long Term Debt

Annual Long Term Debt

$3.05 B
-$452.21 M-12.92%

31 December 2023

NVO Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Debt

$7.71 B
+$298.15 M+4.02%

30 September 2024

NVO Quarterly Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVO Long Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.9%+173.1%
3 y3 years+536.5%+298.4%
5 y5 years-+1696.7%

NVO Long Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-12.9%+536.5%at high+298.4%
5 y5 years-12.9%+575.6%at high+1767.9%
alltimeall time-12.9%+5938.0%at high>+9999.0%

Novo Nordisk A/S Long Term Debt History

DateAnnualQuarterly
Sept 2024
-
$7.71 B(+4.0%)
June 2024
-
$7.41 B(+205.5%)
Mar 2024
-
$2.42 B(-20.4%)
Dec 2023
$3.05 B(-12.9%)
$3.05 B(+8.0%)
Sept 2023
-
$2.82 B(-0.4%)
June 2023
-
$2.83 B(-20.2%)
Mar 2023
-
$3.55 B(+1.5%)
Dec 2022
$3.50 B(+77.4%)
$3.50 B(+9.7%)
Sept 2022
-
$3.19 B(-6.0%)
June 2022
-
$3.39 B(-6.1%)
Mar 2022
-
$3.61 B(+83.2%)
Dec 2021
$1.97 B(+312.1%)
$1.97 B(+2.0%)
Sept 2021
-
$1.93 B(-3.0%)
June 2021
-
$1.99 B(+346.8%)
Mar 2021
-
$446.37 M(-6.8%)
Dec 2020
$478.83 M(+6.1%)
$478.83 M(+15.2%)
Sept 2020
-
$415.63 M(+0.7%)
June 2020
-
$412.59 M(-2.5%)
Mar 2020
-
$423.27 M(-6.2%)
Dec 2019
$451.12 M(+415.7%)
$451.12 M(+5.2%)
Sept 2019
-
$428.92 M(-5.4%)
June 2019
-
$453.53 M(-5.8%)
Mar 2019
-
$481.50 M(+452.8%)
Sept 2012
-
$87.09 M(+3.7%)
June 2012
-
$84.01 M(-8.1%)
Mar 2012
-
$91.44 M(+4.5%)
Dec 2011
$87.48 M(-2.7%)
$87.48 M(-4.5%)
Sept 2011
-
$91.62 M(-6.3%)
June 2011
-
$97.81 M(+2.5%)
Mar 2011
-
$95.40 M(+6.1%)
Dec 2010
$89.91 M(-51.8%)
$89.91 M(-50.6%)
Sept 2010
-
$181.89 M(+8.8%)
June 2010
-
$167.10 M(-4.8%)
Mar 2010
-
$175.60 M(-5.9%)
Dec 2009
$186.57 M(+1.0%)
$186.57 M(-1.5%)
Sept 2009
-
$189.47 M(+2.7%)
June 2009
-
$184.52 M(+2.8%)
Mar 2009
-
$179.55 M(-2.8%)
Dec 2008
$184.70 M
$184.70 M(+0.4%)
DateAnnualQuarterly
Sept 2008
-
$184.04 M(-6.2%)
June 2008
-
$196.11 M(-0.2%)
Mar 2008
-
$196.46 M(+4.5%)
Dec 2007
$188.02 M(-9.6%)
$188.02 M(-13.3%)
Sept 2007
-
$216.88 M(+2.8%)
June 2007
-
$211.00 M(+0.5%)
Mar 2007
-
$210.00 M(+1.0%)
Dec 2006
$207.88 M(+5.0%)
$207.88 M(+3.4%)
Sept 2006
-
$201.00 M(-0.4%)
June 2006
-
$201.83 M(+2.0%)
Mar 2006
-
$197.78 M(-0.1%)
Dec 2005
$198.00 M(-9.1%)
$198.00 M(-3.4%)
Sept 2005
-
$204.89 M(-0.4%)
June 2005
-
$205.70 M(-5.3%)
Mar 2005
-
$217.12 M(-0.3%)
Dec 2004
$217.79 M(+70.1%)
$217.79 M(+74.2%)
Sept 2004
-
$125.03 M(+7.0%)
June 2004
-
$116.87 M(-7.9%)
Mar 2004
-
$126.92 M(-0.9%)
Dec 2003
$128.00 M(+10.4%)
$128.00 M(+10.4%)
Dec 2002
$115.90 M(+13.7%)
$115.90 M(+13.7%)
Dec 2001
$101.97 M(-13.6%)
$101.97 M(-13.6%)
Dec 2000
$118.01 M(-13.0%)
$118.01 M(-13.0%)
Dec 1999
$135.70 M(-52.8%)
$135.70 M(-52.8%)
Dec 1998
$287.31 M(+11.1%)
$287.31 M(+11.1%)
Dec 1997
$258.61 M(+62.5%)
$258.61 M(+62.5%)
Dec 1996
$159.17 M(-33.1%)
$159.17 M(-33.1%)
Dec 1995
$238.01 M(-53.4%)
$238.01 M(-53.4%)
Dec 1994
$510.82 M(+3.4%)
$510.82 M(+3.4%)
Dec 1993
$493.92 M(+19.4%)
$493.92 M(+19.4%)
Dec 1992
$413.52 M(+42.7%)
$413.52 M(+42.7%)
Dec 1991
$289.81 M(+46.9%)
$289.81 M(+46.9%)
Dec 1990
$197.30 M(-16.5%)
$197.30 M(-16.5%)
Dec 1989
$236.42 M(+93.4%)
$236.42 M(+93.4%)
Dec 1988
$122.26 M(-15.2%)
$122.26 M(-15.2%)
Dec 1987
$144.25 M(+15.2%)
$144.25 M(+15.2%)
Dec 1986
$125.17 M(+52.4%)
$125.17 M(+52.4%)
Dec 1985
$82.15 M(+62.7%)
$82.15 M(+62.7%)
Dec 1984
$50.48 M
$50.48 M

FAQ

  • What is Novo Nordisk A/S annual long term debt?
  • What is the all time high annual long term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual long term debt year-on-year change?
  • What is Novo Nordisk A/S quarterly long term debt?
  • What is the all time high quarterly long term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly long term debt year-on-year change?

What is Novo Nordisk A/S annual long term debt?

The current annual long term debt of NVO is $3.05 B

What is the all time high annual long term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual long term debt is $3.50 B

What is Novo Nordisk A/S annual long term debt year-on-year change?

Over the past year, NVO annual long term debt has changed by -$452.21 M (-12.92%)

What is Novo Nordisk A/S quarterly long term debt?

The current quarterly long term debt of NVO is $7.71 B

What is the all time high quarterly long term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly long term debt is $7.71 B

What is Novo Nordisk A/S quarterly long term debt year-on-year change?

Over the past year, NVO quarterly long term debt has changed by +$4.88 B (+173.11%)